1Pedersen TR.Scandinavian Simvastatin Survival Study Group.Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study I (4S)[J].Lancet,1994,344(8934):1383-1389
2Shepherd J,Cobbe SM,Ford 1,et al.West of Scotland Coronary Prevention Study Group.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N EngI J Med,1995,333(20):1301-1308
3Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events Trial Investigators[J].N EngI J Med,1996,335(14):1001-1009
4LIPID Study Group.Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study:a randomized trial in patients acute myocardial infarction and / or unstable angina pectoris[J].Am J Cardiol,1995,76 (7):474-483
5Downs JR,Clearfield M.Weis S,et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS / Tex CAPS[J].JAMA,1998,299 (20):1615-1622
8Schwartz G G,Olsson A G,Ezekowitz M D,et al.Effects of atorvsstatin on early recurrent ischemia events in acute coronary syndrome.The MIRACL Study,A randomized clinical trial[J].JAMA,2001,285 (3):1711-1718
9Dupuis J,Tardif T C,Throux P.Cholesterol reduction rapidly improved endothelial function after acute coronary syndrome[J].J Am Coll Cardiol,1998,31 (Suppl A):S891-S897
1[4]Randomised trial of cholesterol lovering in 4444 patients with coronary heart disease, the scandinavian simvastatin survival Study(4s) [J]. Lancet, 1994. 344: 1383-1389.
2Farnier M, Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol, 1998, 82: 3J - 10J.
3Scandinavian Simvastatin Survival Study Gtoup.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival study(4S). Lancet, 1994, 344:1383 - 1389.
4Sacks FM, Pfeffer MA, Moye LA, et al. for the cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996, 335:1001 - 1009.
5The Long-Term Intervention with Pravastatin ia Ischaemic Disease(LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998, 339:1349 - 1357.
6Plehn JF, Davis BR Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events(CARE)study. the CARE Investigators. Circulation,1999, 99:216 -223.
7Pedersen TR, Kjekshus J, Pyorala K, et al. Eeffect of simvastatin on ischemia signs and symptoms ia the Scandinavian Simvastatin Survival Study(4S). Am J Cardiol, 1998, 81:333 -335.
8Shepherd J, Cobbe SM, Ford I, et al. for the West Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med,1995, 333:1301 - 1307.
9Crouse JR, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med, 1997, 157:1305 -1310.
10Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/Tex CAPS Research Group. Primary prevention of acute coronary events with lovastatin ka men and women with average cholesterol levels. JAMA,1998, 279:1515 - 1622.
